OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Neurology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Update on management of cerebral venous thrombosis	78
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	61
Management of neuropsychiatric symptoms in dementia	52
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	49
The recent surge of functional movement disorders: social distress or greater awareness?	48
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	46
The role of the gut microbiome in Alzheimer's disease pathophysiology	42
Editorial introductions	40
Microglia in multiple sclerosis – pathogenesis and imaging	39
Central nervous system adverse events of immune checkpoint inhibitors	33
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	33
Historical development and contemporary use of neuromodulation in human spinal cord injury	29
Hereditary motor neuropathies	29
Neurology education in the era of artificial intelligence	29
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	29
Gene therapies for CMT neuropathies: from the bench to the clinic	27
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	26
From basic mechanisms to therapeutic perspectives in cluster headache	25
Editorial introductions	24
Multiple sclerosis in China: the current state of diagnosis and management	22
Updates in neuro-otology	21
Editorial: Epilepsy advances in 2023	21
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	21
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	21
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	21